Strategy to Boost Prostate Cancer Treatment Efficacy Devised at Rutgers Health
January 23, 2024
January 23, 2024
NEW BRUNSWICK, New Jersey, Jan. 23 (TNSres) -- Rutgers University issued the following news:
Rutgers researchers can predict which patients will benefit from a popular prostate cancer drug - and have devised a strategy that may make the treatment work longer.
"This work should help doctors know which patients' prostate cancers will and won't respond to the androgen deprivation therapy enzalutamide, which can slow prostate cancer growth by disrupting androgen recept . . .
Rutgers researchers can predict which patients will benefit from a popular prostate cancer drug - and have devised a strategy that may make the treatment work longer.
"This work should help doctors know which patients' prostate cancers will and won't respond to the androgen deprivation therapy enzalutamide, which can slow prostate cancer growth by disrupting androgen recept . . .